Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat. (2019)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.exphem.2019.09.025
PubMed Identifier: 31563618
Publication URI: http://europepmc.org/abstract/MED/31563618
Type: Journal Article/Review
Volume: 79
Parent Publication: Experimental hematology
ISSN: 0301-472X